The West Virginia Racing Commission in late summer or early fall plans to hold a fact-finding meeting on use of furosemide on race day, officials said Aug. 4.
- By Tom LaMarra
The majority of National Horsemen's Benevolent and Protective Association affiliates have adopted resolutions calling for continued regulated use of furosemide on race day.
Adding weight to horses racing on Salix would eliminate 'advantage' read blog
While many of racing's major issues were discussed at the July 25 meeting of the board of directors of the Association of Racing Commissioners International, the agenda called for few decisions to be made.
Some of racing's most notable owners pledged to race 2-year-olds of 2012 without furosemide and adjunct bleeder medications, TOBA announced July 19.
Hollywood Casino at Penn National Race Course is the first of three Pennsylvania Thoroughbred tracks to require administration of race-day furosemide by third-party veterinarians.
The Association of Racing Commissioners International is reassessing its policy supporting race-day administration of furosemide, but also indicated much needs to be done before any change is made.
During a June 29 meeting that showed the battle over race-day furosemide is escalating, supporters ripped their opponents and vowed to take their case -- that the medication is good for the racehorse -- to the public.
Did you miss the live show? Listen now to the archived, on demand, version. Listen Now!
- By Tom LaMarra
Regulators around the country are examining the Kentucky Horse Racing Commission's move to phase out race-day furosemide in graded and listed stakes beginning in 2014, but there doesn't appear to be a rush to follow suit.
The controversial subject of furosemide, the anti-bleeder medication widely used in North American racing, will be the subject of the next "Talkin' Horses with The Blood-Horse" live podcast at 2 p.m. EDT, Tuesday, June 26.
- By Tom LaMarra
The Thoroughbred Racing Associations has endorsed a policy for medication reform that has been supported by many industry stakeholders but so far acted upon piecemeal in various jurisdictions.
Some foreign racing organizations issued statements June 14 backing action by the Kentucky Horse Racing Commission to phase out use of race-day furosemide in graded and listed stakes over three years beginning Jan. 1, 2014.
The Kentucky Horse Racing Commission, by a 7-5 vote with one abstention June 13, approved an administrative regulation that would ban the use of furosemide on race day in graded and listed stakes over a three-year period.
In a development that figures to play out in other racing states, two New York senators said June 12 the anti-bleeding medication furosemide should not be banned on race day.
In advance of an expected vote by the Kentucky Horse Racing Commission June 13, the American Graded Stakes Committee reaffirmed its desire to ban all race-day medication in graded stakes for 2-year-olds.
During an oddly lopsided meeting on a proposal to phase-out use of furosemide on race day in listed and graded stakes in Kentucky, proponents of the therapeutic anti-bleeding medication made their case. But it may not matter.
A new law that allows for an expansion of racetrack card clubs in Minnesota also permits the Minnesota Racing Commission to set threshold testing levels for therapeutic medications used in racehorses.
The Kentucky Horse Racing Commission has scheduled a town hall meeting for June 5 to discuss the proposed three-year phase-out of the race-day drug furosemide.
There doesn't seem to be any middle ground in the debate over the anti-bleeding drug furosemide, and it seems doubtful the two sides will come together any time soon.
The Kentucky Horse Racing Commission May 16 kept alive a proposed regulation to phase out over three years race-day furosemide for graded and listed stakes, but not before the Equine Drug Research Council voted to reject it.
The Jockey Club May 15 released an eight-page letter it submitted to the New York State Racing and Wagering Board the previous day in regard to use of the race-day medication and furosemide and other related issues.
The Thoroughbred Owners and Breeders Association is the latest organization to respond to the New York State Racing and Wagering Board with its opinions on the use of the anti-bleeding medication furosemide on race day.
The Kentucky Horse Racing Commission confirmed it will discuss but not take final action May 16 on a proposal for the three-year phase-out of race-day furosemide in graded and listed stakes.
Darby Dan Farms owner John Phillips has been appointed to the Kentucky Horse Racing Commission as a replacement for John Ward Jr., who recently was hired as executive director of the regulatory agency.
The racing industry is closer to uniformity in drug regulations and penalties than many admit, but agreement on race-day anti-bleeding drugs in a "toxic" environment will require some heavy lifting, officials said May 2.
Thoroughbred racing got further bruises April 30 during an allegation-ridden congressional hearing into equine health and medication issues that furthered a call for federal intervention--at least on some level.
The use and possible abuse of therapeutic medications will be dominating the discussions throughout the 78th annual Conference on Racing and Wagering Integrity underway in Oklahoma City April 25.
Industry organizations are taking a wait-and-see approach to an April 30 hearing at which members of Congress will examine health and safety issues in horse racing--and whether progress has been made since the last hearing.
An effort to make Kentucky the first state to ban the anti-bleeder medication furosemide for racing purposes failed April 16 when the state's Horse Racing Commission voted 7-7 not to approve it.
The Kentucky Horsemen's Benevolent and Protective Association has requested Gov. Steve Beshear not to sign any request to implement on an emergency basis a ban on race-day use of furosemide.
The West Virginia Racing Commission voted April 13 to ban the use of adjunct bleeder medications on race day and to adopt much stricter penalties for drug violations.
- By Tom LaMarra
The Jockey Club officially released its "Reformed Racing Medication Rules" March 30, but broad adoption of the policies hinges on action by regulators in all racing jurisdictions.
Members of the National Thoroughbred Racing Association Safety and Integrity Alliance have been given the updated code of standards for 2012, officials said March 12.
Breeders' Cup Ltd. has reaffirmed its plan to ban race-day medications in World Championships races for 2-year-olds this year, despite recent action by the American Graded Stakes Committee to delay a similar ban.
Delaware Park was awarded 100 days of live Thoroughbred racing for 2012, but the track has no contract with the Delaware Thoroughbred Horsemen's Association for the meet.
Panelists gathered for a Jan. 14 National Horsemen's Benevolent and Protective Association forum said there is no scientific evidence supporting a ban on the use of furosemide on race day.
The National Horsemen's Benevolent and Protective Association will tackle several issues, including governmental affairs, high volume pari-mutuel bettors, and use of furosemide on race day during its convention Jan. 12-16.
The Association of Racing Commissioners International Model Rules Committee has adopted protocol that prohibits private veterinarians from administering furosemide on race day.
If testimony taken Nov. 14 in Kentucky, a major breeding and racing state, is any indication, the battle over use of furosemide on race day doesn't figure to end any time soon.
The pros and cons of race-day medication in racehorses were debated Nov. 14 during a lengthy meeting of the Kentucky Horse Racing Commission Race Day Medication Committee at the state Capitol.
The Racing Medication and Testing Consortium (RMTC) board of directors heard important updates from the organization's race day medication, drug testing initiative (DTI), and research committees during a meeting Oct. 6.
A New York lawmaker said Sept. 13 he will introduce legislation banning use of "performance-enhancing drugs" such as the anti-bleeding medication furosemide, or Salix.
- By Tom LaMarra
Racing industry officials said a report that shows 99.5% of biological samples taken from racehorses and tested by laboratories in 2010 were "clean" dispels claims that horse racing is drug-ridden.
An industry consortium supports administration of Salix by regulatory veterinarians only and a ban on adjunct bleeder drugs, but will continue to study a pilot program proposal to ban the use of race-day Salix in 2-year-olds.
Two panels of the Kentucky Horse Racing Commission have begun the lengthy--and potentially contentious--process of reviewing and revising the state's medication regulations.
A baby step toward progress was how organizers described the two-day International Race Day Medication Summit held June 13-14 at Belmont Park.
A well-attended summit June 13 at Belmont Park shed a lot of light on the research and international regulations surrounding the race-day medication Salix.
Jockey Club president James Gagliano reiterates call for ban on race-day medications.
The RCI board of directors voted without objection this week in favor of a resolution calling for the re-examination of whether its current policy pertaining to furosemide should be continued.
Most Popular Stories
- Hoppertunity Stays Up in Roughshod Rebel
- Let Faith Arise Puts Santa Margarita On Ice
- Featured Horse Profile: Close Hatches
- Onlyforyou Euthanized After Training Accident
- Close Hatches Proves Class in Azeri Stakes
- Golden Lad Pulls Away for Razorback Romp
- Centre Court Scores Game Honey Fox Repeat
- Arkansas Derby Preview Day Preview Blog
- Cairo Prince Leads Florida Derby Worktab
- Champs Beholder, She's a Tiger Post Workouts